Ads
related to: antibody
Search results
Innovent Announces Oral Presentations at ESMO Plenary and ESMO GI Congress on Clinical Data of...
CBS 47 Fresno· 2 days ago...develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces that the company will deliver oral presentations on clinical data of its first-in-class PD-1/IL-2 bispecific ...
Lung cancer: Pre- and postsurgical immunotherapy may improve outcomes
Medical News Today· 16 hours agoLung cancer is a major cause of all cancer-related deaths, with some treatment options involving...
AstraZeneca to build $1.5bn ADCs facility in Singapore
Investment Monitor via Yahoo Finance· 2 days agoPharmaceutical giant AstraZeneca has announced plans to invest $1.5bn in a new antibody-drug...
Hansa Biopharma to present data at 2024 American Transplant Congress annual meeting
FOX 59 Indianapolis· 1 day agoHansa Biopharma, "Hansa" (NASDAQ: HNSA) (STOCKHOLM: HNSA), today announced data featuring imlifidase...
FDA approves Amgen drug for tough-to-treat form of lung cancer
BioPharma Dive via Yahoo Finance· 5 days agoImdelltra, a bispecific antibody targeting a protein called DLL3, is cleared for use following...
Once-Promising Drug for Idiopathic Pulmonary Fibrosis Fails in Phase III Trial
MedPage Today· 2 days agoThe fully human monoclonal antibody pamrevlumab failed to improve lung function among patients with...
AstraZeneca prepares fresh COVID push to regulators after antibody's phase 3 success
FierceBiotech· 6 days agoResults from the phase 3 SUPERNOVA study show that the company’s investigational long-acting ...
New tool may help identify infants at high risk for poor RSV outcomes
Center for Infectious Disease Research and Policy· 13 hours agoThe tool may also help address any family hesitancy about giving the RSV monoclonal antibody by...
Cantargia Publishes Interim Report for the First Quarter of 2024
Digital Journal· 23 hours agoSignificant events in the first quarter The first results from the ongoing clinical phase 1 study of CAN10 show that the antibody binds to the target IL1RAP and shows good ...
Johnson & Johnson to acquire Proteologix for $850 million
Reuters via Yahoo Finance· 6 days agoProteologix's antibody PX128 is ready to enter early-stage development for moderate to severe atopic...